Covered recipient · General Payments record
ROBERT T GUNBY
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2018–2024
$5,018.96
- Reported across 165 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $800.00 | 2 |
| Food and Beverage | $317.53 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| MIMEDX Group, Inc. | $800.00 | 2 |
| SHIELD THERAPEUTICS INC | $131.00 | 2 |
| MILLICENT US INC | $39.12 | 2 |
| PFIZER INC. | $37.05 | 2 |
| Exact Sciences Corporation | $26.78 | 1 |
| Sumitomo Pharma America, Inc. | $21.93 | 1 |
| Merck Sharp & Dohme Corporation | $20.23 | 1 |
| Meditrina | $14.30 | 1 |
| CooperSurgical, Inc. | $13.98 | 1 |
| ASCEND THERAPEUTICS US, LLC | $13.14 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ASCEND THERAPEUTICS US, LLC | $13.14 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146421973 | CMS |
| CooperSurgical, Inc. | $13.98 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150802062 | CMS |
| Exact Sciences Corporation | $26.78 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114686245 | CMS |
| Meditrina | $14.30 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154267488 | CMS |
| Merck Sharp & Dohme LLC | $20.23 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141574652 | CMS |
| MILLICENT US INC | $20.46 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150907576 | CMS |
| MILLICENT US INC | $18.66 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150907579 | CMS |
| MIMEDX Group, Inc. | $400.00 | 04/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1140260247 | CMS |
| MIMEDX Group, Inc. | $400.00 | 05/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1140260249 | CMS |
| PFIZER INC. | $17.38 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130988775 | CMS |
| PFIZER INC. | $19.67 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131506692 | CMS |
| SHIELD THERAPEUTICS INC | $50.80 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150139667 | CMS |
| SHIELD THERAPEUTICS INC | $80.20 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150152840 | CMS |
| Sumitomo Pharma America, Inc. | $21.93 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148859747 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.